Model systems for aromatic nitro group reduction--relationships to tissue catalyzed reagents.
D062365:Aminobenzoates / Q000378:metabolism; D000818:Animals; D001565:Benzoates / Q000378:metabolism*; D001693:Biological Transport, Active; D001769:Blood; D002248:Carbon Monoxide / Q000494:pharmacology; D003545:Cysteine / Q000378:metabolism; D003956:Dialysis; D004583:Electrons; D005260:Female; D005486:Flavin Mononucleotide / Q000378:metabolism; D005182:Flavin-Adenine Dinucleotide / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007202:Indicators and Reagents / Q000494:pharmacology; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008954:Models, Biological; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D014020:Tissue Extracts / Q000378:metabolism
D062365:Aminobenzoates; D001565:Benzoates; D007202:Indicators and Reagents; D014020:Tissue Extracts; D009243:NAD; D005182:Flavin-Adenine Dinucleotide; D009249:NADP; D005486:Flavin Mononucleotide; D002248:Carbon Monoxide; D005978:Glutathione; D003545:Cysteine